Amylyx’s bet on a GLP-1 blocker pays off
admin Boston-area biopharmaceutical company Amylyx Pharmaceuticals has reported overwhelmingly positive results from a pivotal Phase 3...
biotech
Cancer Research Institute Announces 2026 Lloyd J. Old STARs: A $6.25 Million Investment in Immunotherapy’s Future
The Cancer Research Institute (CRI) has proudly unveiled the 2026 class of its prestigious Lloyd...
Leo Pharma Bolsters Rare Dermatology Portfolio with Acquisition of Dersimelagon, an Oral Therapy for Severe Sunlight Sensitivity.
Copenhagen, Denmark — Leo Pharma A/S, a global leader in medical dermatology, has significantly expanded...
Nobel Laureate Susumu Tonegawa, Pioneering Immunologist and Neuroscientist, Dies at 86
The global scientific community is in mourning following the passing of Dr. Susumu Tonegawa, a...
Biopharma Industry Sees Breakthroughs in Lung Cancer, Biosimilar Deals, Legal Battles, and Strategic Partnerships
The biopharmaceutical landscape continues to evolve rapidly, marked by significant advancements in oncology, strategic collaborations...
BioMarin Bolsters Pipeline with Alesta Acquisition, Targeting Broad Patient Population in Muscle and Skeletal Diseases
BioMarin Pharmaceutical Inc. announced on August 18, 2026, the acquisition of Alesta Therapeutics, a Netherlands-based...
The Cancer Research Institute Launches IGNITE Award, Bridging Critical Funding Gap for Next-Generation Cancer Immunotherapy Leaders
In October 2025, the Cancer Research Institute (CRI) made a landmark announcement, unveiling the IGNITE...
Dr. Heidi Overton Nominated to Key Role Amidst FDA Turmoil, Sparking Industry Uncertainty
The Trump administration has announced the nomination of Dr. Heidi Overton, a medical doctor, veteran...
July Marks Ultraviolet Radiation Safety Awareness Month Amidst Advancements in Skin Cancer Prevention and Immunotherapy
As July unfolds, designated as Ultraviolet (UV) Radiation Safety Awareness Month, public health organizations and...
Zipalertinib Emerges as Potent Challenger in EGFR Exon 20 NSCLC Treatment Landscape, Setting New Standards for Efficacy and Market Competition.
In a significant development for oncology, Taiho Oncology and Cullinan Therapeutics have announced compelling positive...
